{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:20:34Z","timestamp":1793481634751,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04375-2","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T23:01:43Z","timestamp":1756162903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glutamatergic and GABAergic metabolite levels in Alzheimer\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Rasoul","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Mohammad Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Masouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Seifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Ghafourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokoofe","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"4375_CR1","unstructured":"World Health Organization. A blueprint for dementia research. Geneva: World Health Organization; 2022. https:\/\/iris.who.int\/handle\/10665\/363341. License: CC BY-NC-SA 3.0 IGO."},{"key":"4375_CR2","volume-title":"Alzheimer disease","author":"A Kumar","year":"2024","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW. Alzheimer disease. StatPearls [internet]: StatPearls Publishing; 2024."},{"issue":"1","key":"4375_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4375_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13195-023-01254-1","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, Sun Y, Xie X, Zhao Y. Blood and CSF chemokines in alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Res Ther. 2023;15(1):107.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"4375_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362(4):329\u201344.","journal-title":"N Engl J Med"},{"issue":"6","key":"4375_CR6","doi-asserted-by":"publisher","first-page":"103039","DOI":"10.1016\/j.arcmed.2024.103039","volume":"55","author":"SK Castillo-Vazquez","year":"2024","unstructured":"Castillo-Vazquez SK, Massieu L, Rinc\u00f3n-Heredia R, Garc\u00eda-de la Torre P, Quiroz-Baez R, Gomez-Verjan JC, et al. Glutamatergic neurotransmission in aging and neurodegenerative diseases: A potential target to improve cognitive impairment in aging. Arch Med Res. 2024;55(6):103039.","journal-title":"Arch Med Res"},{"issue":"4","key":"4375_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1049\u201369.","journal-title":"J Alzheimers Dis"},{"key":"4375_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13578-020-00393-4","volume":"10","author":"X Du","year":"2020","unstructured":"Du X, Li J, Li M, Yang X, Qi Z, Xu B, et al. Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases. Cell Biosci. 2020;10:26.","journal-title":"Cell Biosci"},{"issue":"8","key":"4375_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna). 2014;121(8):799\u2013817.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"4375_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","volume":"14","author":"C Abdelnour","year":"2022","unstructured":"Abdelnour C, Agosta F, Bozzali M, Foug\u00e8re B, Iwata A, Nilforooshan R, et al. Perspectives and challenges in patient stratification in alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):112.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"4375_CR11","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1038\/s41598-019-49356-x","volume":"9","author":"M Crabb\u00e9","year":"2019","unstructured":"Crabb\u00e9 M, Dirkx N, Casteels C, Laere KV. Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study. Sci Rep. 2019;9(1):12916.","journal-title":"Sci Rep"},{"issue":"1","key":"4375_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","volume":"12","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12(1):257.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"4375_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J. New approaches to symptomatic treatments for alzheimer\u2019s disease. Mol Neurodegener. 2021;16(1):2.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"4375_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222\u201334.","journal-title":"Lancet Neurol"},{"key":"4375_CR15","doi-asserted-by":"publisher","first-page":"654931","DOI":"10.3389\/fnagi.2021.654931","volume":"13","author":"A Gasiorowska","year":"2021","unstructured":"Gasiorowska A, Wydrych M, Drapich P, Zadrozny M, Steczkowska M, Niewiadomski W, et al. The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain. Front Aging Neurosci. 2021;13:654931.","journal-title":"Front Aging Neurosci"},{"key":"4375_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-08894-5_2","volume":"11","author":"A Schousboe","year":"2014","unstructured":"Schousboe A, Scafidi S, Bak LK, Waagepetersen HS, McKenna MC. Glutamate metabolism in the brain focusing on astrocytes. Adv Neurobiol. 2014;11:13\u201330.","journal-title":"Adv Neurobiol"},{"key":"4375_CR17","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.neuropharm.2021.108719","volume":"196","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, et al. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology. 2021;196:108719.","journal-title":"Neuropharmacology"},{"key":"4375_CR18","doi-asserted-by":"publisher","first-page":"1037641","DOI":"10.3389\/fncel.2022.1037641","volume":"16","author":"AO Cuellar-Santoyo","year":"2022","unstructured":"Cuellar-Santoyo AO, Ruiz-Rodr\u00edguez VM, Mares-Barbosa TB, Patr\u00f3n-Soberano A, Howe AG, Portales-P\u00e9rez DP, et al. Revealing the contribution of astrocytes to glutamatergic neuronal transmission. Front Cell Neurosci. 2022;16:1037641.","journal-title":"Front Cell Neurosci"},{"key":"4375_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","volume":"92","author":"L Ding","year":"2021","unstructured":"Ding L, Xu X, Li C, Wang Y, Xia X, Zheng JC. Glutaminase in microglia: A novel regulator of neuroinflammation. Brain Behav Immun. 2021;92:139\u201356.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"4375_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/alz.12792","volume":"19","author":"S Katabathula","year":"2023","unstructured":"Katabathula S, Davis PB, Xu R. Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of alzheimer\u2019s disease. Alzheimers Dement. 2023;19(4):1428\u201339.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"4375_CR21","doi-asserted-by":"publisher","first-page":"e14617","DOI":"10.1111\/cns.14617","volume":"30","author":"D Zhang","year":"2024","unstructured":"Zhang D, Hua Z, Li Z. The role of glutamate and glutamine metabolism and related transporters in nerve cells. CNS Neurosci Ther. 2024;30(2):e14617.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"4375_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1039\/D3AY01488F","volume":"16","author":"X Gong","year":"2024","unstructured":"Gong X, Guo R, Li X, Yang Y, Lin W. A red-emitting mitochondria targetable fluorescent probe for detecting viscosity in hela, zebrafish, and mice. Anal Methods. 2024;16(2):293\u2013300.","journal-title":"Anal Methods"},{"issue":"13","key":"4375_CR23","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1039\/D1FO00505G","volume":"12","author":"A Liu","year":"2021","unstructured":"Liu A, Lin L, Xu W, Gong Z, Liu Z, Xiao W. L-Theanine regulates glutamine metabolism and immune function by binding to cannabinoid receptor 1. Food Funct. 2021;12(13):5755\u201369.","journal-title":"Food Funct"},{"key":"4375_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neures.2017.11.010","volume":"134","author":"K Fukumoto","year":"2018","unstructured":"Fukumoto K, Tamada K, Toya T, Nishino T, Yanagawa Y, Takumi T. Identification of genes regulating GABAergic interneuron maturation. Neurosci Res. 2018;134:18\u201329.","journal-title":"Neurosci Res"},{"issue":"2","key":"4375_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1567205014666170921122458","volume":"15","author":"R Manyevitch","year":"2018","unstructured":"Manyevitch R, Protas M, Scarpiello S, Deliso M, Bass B, Nanajian A, et al. Evaluation of metabolic and synaptic dysfunction hypotheses of alzheimer\u2019s disease (AD): A Meta-Analysis of CSF markers. Curr Alzheimer Res. 2018;15(2):164\u201381.","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"4375_CR26","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1038\/s41380-023-02140-w","volume":"28","author":"G Carello-Collar","year":"2023","unstructured":"Carello-Collar G, Bellaver B, Ferreira PCL, Ferrari-Souza JP, Ramos VG, Therriault J, et al. The GABAergic system in alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry. 2023;28(12):5025\u201336.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"4375_CR27","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/s41380-024-02473-0","volume":"29","author":"C Soares","year":"2024","unstructured":"Soares C, Da Ros LU, Machado LS, Rocha A, Lazzarotto G, Carello-Collar G, et al. The glutamatergic system in alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry. 2024;29(7):2261\u201373.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4375_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"key":"4375_CR29","unstructured":"Rayyan. [Available from: https:\/\/www.rayyan.ai\/"},{"key":"4375_CR30","unstructured":"WebPlotDigitizer. [Available from: https:\/\/apps.automeris.io\/wpd4\/"},{"key":"4375_CR31","unstructured":"Critical Appraisal Tools. [Available from: https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"4375_CR32","unstructured":"National Institutes of Health (NIH). National Heart, Lung, and Blood Institute (NHLBI), Study Quality Assessment Tools, Unites States; July, 2021 [Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"issue":"1","key":"4375_CR33","first-page":"1","volume":"61","author":"MILLER RG","year":"1974","unstructured":"MILLER RG. The jackknife-a review. Biometrika. 1974;61(1):1\u201315.","journal-title":"Biometrika"},{"key":"4375_CR34","doi-asserted-by":"publisher","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Routledge;\u00a01988.\u00a0https:\/\/doi.org\/10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"issue":"1","key":"4375_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jrsm.1230","volume":"8","author":"M Borenstein","year":"2017","unstructured":"Borenstein M, Higgins JP, Hedges LV, Rothstein HR. Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8(1):5\u201318.","journal-title":"Res Synth Methods"},{"key":"4375_CR36","unstructured":"Lenhard WL. A. Computation of effect sizes. Retrieved from: https:\/\/www.psychometrica.de\/effect_size.html. Psychometrica. 2022."},{"issue":"1","key":"4375_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","volume":"24","author":"A Abbas","year":"2024","unstructured":"Abbas A, Hefnawy MT, Negida A. Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis. BMC Med Res Methodol. 2024;24(1):243.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"4375_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.freeradbiomed.2004.05.028","volume":"37","author":"B Begni","year":"2004","unstructured":"Begni B, Brighina L, Sirtori E, Fumagalli L, Andreoni S, Beretta S, et al. Oxidative stress impairs glutamate uptake in fibroblasts from patients with alzheimer\u2019s disease. Free Radic Biol Med. 2004;37(6):892\u2013901.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"4375_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02815405","volume":"23","author":"GH Fisher","year":"1994","unstructured":"Fisher GH, Petrucelli L, Gardner C, Emory C, Frey WH, Amaducci L, et al. FREE D-AMINO ACIDS IN HUMAN CEREBROSPINAL-FLUID OF ALZHEIMER-DISEASE, MULTIPLE-SCLEROSIS, AND HEALTHY CONTROL SUBJECTS. Mol Chem Neuropathol. 1994;23(2):115\u201324.","journal-title":"Mol Chem Neuropathol"},{"issue":"6","key":"4375_CR40","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/jnc.15937","volume":"166","author":"JY Cheng","year":"2023","unstructured":"Cheng JY, Deng YT, Yu JT. The causal role of Circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study. J Neurochem. 2023;166(6):972\u201381.","journal-title":"J Neurochem"},{"key":"4375_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CIA.S239350","volume":"15","author":"CD Adams","year":"2020","unstructured":"Adams CD. Circulating glutamine and alzheimer\u2019s disease: A Mendelian randomization study. Clin Interv Aging. 2020;15:185\u201393.","journal-title":"Clin Interv Aging"},{"issue":"6","key":"4375_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1212\/WNL.56.6.737","volume":"56","author":"PG Antuono","year":"2001","unstructured":"Antuono PG, Jones JL, Wang Y, Li SJ. Decreased glutamate\u2009+\u2009glutamine in alzheimer\u2019s disease detected in vivo with (1)H-MRS at 0.5 T. Neurology. 2001;56(6):737\u201342.","journal-title":"Neurology"},{"key":"4375_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dadm.2017.07.006","volume":"8","author":"FA de Leeuw","year":"2017","unstructured":"de Leeuw FA, Peeters CFW, Kester MI, Harms AC, Struys EA, Hankemeier T, et al. Blood-based metabolic signatures in alzheimer\u2019s disease. Alzheimers Dement (Amst). 2017;8:196\u2013207.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"5","key":"4375_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10654-023-00988-4","volume":"38","author":"R Dong","year":"2023","unstructured":"Dong R, Denier-Fields DN, Van Hulle CA, Kollmorgen G, Suridjan I, Wild N, et al. Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting alzheimer\u2019s disease pathology. Eur J Epidemiol. 2023;38(5):559\u201371.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"4375_CR45","doi-asserted-by":"publisher","first-page":"fcae138","DOI":"10.1093\/braincomms\/fcae138","volume":"6","author":"ME Dounavi","year":"2024","unstructured":"Dounavi ME, McKiernan E, Langsen M, Gregory S, Muniz-Terrera G, Prats-Sedano MA, et al. Investigating the brain\u2019s neurochemical profile at midlife in relation to dementia risk factors. Brain Commun. 2024;6(3):fcae138.","journal-title":"Brain Commun"},{"key":"4375_CR46","doi-asserted-by":"publisher","first-page":"796067","DOI":"10.3389\/fnagi.2021.796067","volume":"13","author":"RC Eldridge","year":"2021","unstructured":"Eldridge RC, Uppal K, Shokouhi M, Smith MR, Hu X, Qin ZS, et al. Multiomics analysis of structural magnetic resonance imaging of the brain and cerebrospinal fluid metabolomics in cognitively normal and impaired adults. Front Aging Neurosci. 2021;13:796067.","journal-title":"Front Aging Neurosci"},{"key":"4375_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.chroma.2018.03.041","volume":"1550","author":"YH Hsieh","year":"2018","unstructured":"Hsieh YH, Liao FY, Yang YH, Weng JR, Chen SH, Feng CH. Enantioselective determination of aspartate and glutamate in biological samples by ultrasonic-assisted derivatization coupled with capillary electrophoresis and linked to alzheimer\u2019s disease progression. J Chromatogr A. 2018;1550:68\u201374.","journal-title":"J Chromatogr A"},{"issue":"2","key":"4375_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","volume":"32","author":"AN Fonteh","year":"2007","unstructured":"Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG. Free amino acid and dipeptide changes in the body fluids from alzheimer\u2019s disease subjects. Amino Acids. 2007;32(2):213\u201324.","journal-title":"Amino Acids"},{"key":"4375_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL. Metabolite profiling for the identification of altered metabolic pathways in alzheimer\u2019s disease. J Pharm Biomed Anal. 2015;107:75\u201381.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"4375_CR50","first-page":"154","volume":"7","author":"J Constantinidis","year":"1988","unstructured":"Constantinidis J, GLUTAMATE, GLU) AND GABA IN HIPPOCAMPIC AND LIMBIC AREAS IN ALZHEIMERS-DISEASE. Clin Neuropathol. 1988;7(4):154.","journal-title":"Clin Neuropathol"},{"issue":"6","key":"4375_CR51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/1567205013666160129095138","volume":"13","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2016","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Rup\u00e9rez FJ, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL. Metabolomic-Driven Elucidation of serum disturbances associated with alzheimer\u2019s disease and mild cognitive impairment. Curr Alzheimer Res. 2016;13(6):641\u201353.","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"4375_CR52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JAD-142970","volume":"45","author":"J Hull","year":"2015","unstructured":"Hull J, Patel V, El Hindy M, Lee C, Odeleye E, Hezwani M, et al. Regional increase in the expression of the BCAT proteins in alzheimer\u2019s disease brain: implications in glutamate toxicity. J Alzheimers Dis. 2015;45(3):891\u2013905.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"4375_CR53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/alz.12074","volume":"16","author":"M Cui","year":"2020","unstructured":"Cui M, Jiang Y, Zhao Q, Zhu Z, Liang X, Zhang K, et al. Metabolomics and incident dementia in older Chinese adults: the Shanghai aging study. Alzheimers Dement. 2020;16(5):779\u201388.","journal-title":"Alzheimers Dement"},{"key":"4375_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2024.06.003","volume":"142","author":"CW Davies-Jenkins","year":"2024","unstructured":"Davies-Jenkins CW, Workman CI, Hupfeld KE, Z\u00f6llner HJ, Leoutsakos JM, Kraut MA, et al. Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with (11)C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy. Neurobiol Aging. 2024;142:27\u201340.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4375_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(84)90341-0","volume":"52","author":"AJ Cross","year":"1984","unstructured":"Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Markakis D. Striatal dopamine receptors in Alzheimer-type dementia. Neurosci Lett. 1984;52(1):1\u20136.","journal-title":"Neurosci Lett"},{"issue":"3","key":"4375_CR56","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3233\/JAD-180879","volume":"67","author":"F Hudd","year":"2019","unstructured":"Hudd F, Shiel A, Harris M, Bowdler P, McCann B, Tsivos D, et al. Novel blood biomarkers that correlate with cognitive performance and hippocampal volumetry: potential for early diagnosis of alzheimer\u2019s disease. J Alzheimers Dis. 2019;67(3):931\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4375_CR57","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0306-4522(90)90051-5","volume":"38","author":"SL Lowe","year":"1990","unstructured":"Lowe SL, Bowen DM, Francis PT, Neary D. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in alzheimer\u2019s disease. Neuroscience. 1990;38(3):571\u20137.","journal-title":"Neuroscience"},{"issue":"Pt 4","key":"4375_CR58","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/brain\/111.4.785","volume":"111","author":"SL Lowe","year":"1988","unstructured":"Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM. Gamma-aminobutyric acid concentration in brain tissue at two stages of alzheimer\u2019s disease. Brain. 1988;111(Pt 4):785\u201399.","journal-title":"Brain"},{"key":"4375_CR59","doi-asserted-by":"publisher","first-page":"1326780","DOI":"10.3389\/fnagi.2023.1326780","volume":"15","author":"X Pan","year":"2023","unstructured":"Pan X, Donaghy PC, Roberts G, Chouliaras L, O\u2019Brien JT, Thomas AJ, et al. Plasma metabolites distinguish dementia with lewy bodies from alzheimer\u2019s disease: a cross-sectional metabolomic analysis. Front Aging Neurosci. 2023;15:1326780.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"4375_CR60","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1471-4159.1984.tb02801.x","volume":"42","author":"EK Perry","year":"1984","unstructured":"Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, et al. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between alzheimer\u2019s disease and the normal. J Neurochem. 1984;42(5):1402\u201310.","journal-title":"J Neurochem"},{"issue":"3","key":"4375_CR61","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1471-4159.1988.tb02983.x","volume":"50","author":"AW Procter","year":"1988","unstructured":"Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, et al. Evidence of glutamatergic denervation and possible abnormal metabolism in alzheimer\u2019s disease. J Neurochem. 1988;50(3):790\u2013802.","journal-title":"J Neurochem"},{"issue":"Pt 2","key":"4375_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/brain\/105.2.313","volume":"105","author":"MN Rossor","year":"1982","unstructured":"Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain. 1982;105(Pt 2):313\u201330.","journal-title":"Brain"},{"issue":"6422","key":"4375_CR63","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","volume":"288","author":"MN Rossor","year":"1984","unstructured":"Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M. Neurochemical characteristics of early and late onset types of alzheimer\u2019s disease. Br Med J (Clin Res Ed). 1984;288(6422):961\u20134.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"4375_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s002100000346","volume":"363","author":"R Seidl","year":"2001","unstructured":"Seidl R, Cairns N, Singewald N, Kaehler ST, Lubec G. Differences between GABA levels in alzheimer\u2019s disease and down syndrome with Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch Pharmacol. 2001;363(2):139\u201345.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"4375_CR65","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/jnnp.48.5.469","volume":"48","author":"CC Smith","year":"1985","unstructured":"Smith CC, Bowen DM, Francis PT, Snowden JS, Neary D. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified alzheimer\u2019s dementia. J Neurol Neurosurg Psychiatry. 1985;48(5):469\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4375_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0006-8993(83)91131-9","volume":"264","author":"CCT Smith","year":"1983","unstructured":"Smith CCT, Bowen DM, Sims NR, Neary D, Davison AN. Amino acid release from biopsy samples of Temporal neocortex from patients with alzheimer\u2019s disease. Brain Res. 1983;264(1):138\u201341.","journal-title":"Brain Res"},{"issue":"5","key":"4375_CR67","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1471-4159.1980.tb07883.x","volume":"35","author":"I Tarbit","year":"1980","unstructured":"Tarbit I, Perry EK, Perry RH, Blessed G, Tomlinson BE. Hippocampal free amino acids in alzheimer\u2019s disease. J Neurochem. 1980;35(5):1246\u20139.","journal-title":"J Neurochem"},{"issue":"6","key":"4375_CR68","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0197-4580(87)90122-9","volume":"8","author":"JB Gramsbergen","year":"1987","unstructured":"Gramsbergen JB, Mountjoy CQ, Rossor MN, Reynolds GP, Roth M, Korf J. A correlative study on hippocampal cation shifts and amino acids and clinico-pathological data in alzheimer\u2019s disease. Neurobiol Aging. 1987;8(6):487\u201394.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4375_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2005.06.030","volume":"388","author":"A D\u2019Aniello","year":"2005","unstructured":"D\u2019Aniello A, Fisher G, Migliaccio N, Cammisa G, D\u2019Aniello E, Spinelli P. Amino acids and transaminases activity in ventricular CSF and in brain of normal and alzheimer patients. Neurosci Lett. 2005;388(1):49\u201353.","journal-title":"Neurosci Lett"},{"issue":"5","key":"4375_CR70","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ana.410200510","volume":"20","author":"DW Ellison","year":"1986","unstructured":"Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB. A postmortem study of amino acid neurotransmitters in alzheimer\u2019s disease. Ann Neurol. 1986;20(5):616\u201321.","journal-title":"Ann Neurol"},{"issue":"1","key":"4375_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ana.410220110","volume":"22","author":"BT Hyman","year":"1987","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR. Alzheimer\u2019s disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol. 1987;22(1):37\u201340.","journal-title":"Ann Neurol"},{"issue":"6","key":"4375_CR72","first-page":"670","volume":"93","author":"DE Miulli","year":"1993","unstructured":"Miulli DE, Norwell DY, Schwartz FN. Plasma concentrations of glutamate and its metabolites in patients with alzheimer\u2019s disease. J Am Osteopath Assoc. 1993;93(6):670\u20136.","journal-title":"J Am Osteopath Assoc"},{"issue":"3","key":"4375_CR73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF00230654","volume":"102","author":"P Mohanakrishnan","year":"1995","unstructured":"Mohanakrishnan P, Fowler AH, Vonsattel JP, Husain MM, Jolles PR, Liem P, et al. An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of alzheimer brains. Exp Brain Res. 1995;102(3):503\u201310.","journal-title":"Exp Brain Res"},{"issue":"2","key":"4375_CR74","doi-asserted-by":"publisher","first-page":"B111","DOI":"10.1093\/gerona\/52A.2.B111","volume":"52","author":"P Mohanakrishnan","year":"1997","unstructured":"Mohanakrishnan P, Fowler AH, Vonsattel JP, Jolles PR, Husain MM, Liem P, et al. Regional metabolic alterations in alzheimer\u2019s disease: an in vitro 1H NMR study of the hippocampus and cerebellum. J Gerontol Biol Sci Med Sci. 1997;52(2):B111\u20137.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"4375_CR75","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fnins.2017.00747","volume":"11","author":"M Ore\u0161i\u010d","year":"2017","unstructured":"Ore\u0161i\u010d M, Anderson G, Mattila I, Manoucheri M, Soininen H, Hy\u00f6tyl\u00e4inen T, et al. Targeted serum metabolite profiling identifies metabolic signatures in patients with alzheimer\u2019s disease, normal pressure hydrocephalus and brain tumor. Front Neurosci. 2017;11:747.","journal-title":"Front Neurosci"},{"issue":"6","key":"4375_CR76","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1176\/ajp.146.6.787","volume":"146","author":"N Pomara","year":"1989","unstructured":"Pomara N, Deptula D, Galloway MP, LeWitt PA, Stanley M. CSF GABA in caregiver spouses of alzheimer patients. Am J Psychiatry. 1989;146(6):787\u20138.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"4375_CR77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1176\/ajp.149.2.251","volume":"149","author":"N Pomara","year":"1992","unstructured":"Pomara N, Singh R, Deptula D, Chou JC, Schwartz MB, LeWitt PA. Glutamate and other CSF amino acids in alzheimer\u2019s disease. Am J Psychiatry. 1992;149(2):251\u20134.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"4375_CR78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0006-3223(96)00305-8","volume":"40","author":"MF Weiner","year":"1996","unstructured":"Weiner MF, Speciale SG, Risser RC, Kramer GL, Petty F. Cerebrospinal fluid and plasma gamma-aminobutyric acid in alzheimer\u2019s disease. Biol Psychiatry. 1996;40(9):933\u20134.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"4375_CR79","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00330-016-4669-8","volume":"27","author":"D Huang","year":"2017","unstructured":"Huang D, Liu D, Yin J, Qian T, Shrestha S, Ni H. Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment. Eur Radiol. 2017;27(7):2698\u2013705.","journal-title":"Eur Radiol"},{"issue":"1","key":"4375_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0531-5565(98)00017-5","volume":"34","author":"DT Yew","year":"1999","unstructured":"Yew DT, Li WP, Webb SE, Lai HW, Zhang L. Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and alzheimer patients: a comparison. Exp Gerontol. 1999;34(1):117\u201333.","journal-title":"Exp Gerontol"},{"key":"4375_CR81","doi-asserted-by":"publisher","unstructured":"Zhang Y, Liu Z, Ji B, Liu L, Wu S, Liu X, Wang S, Wang L. Metabolite profile of alzheimer\u2019s disease in the frontal cortex as analyzed by HRMAS 1H NMR. Front Aging Neurosci. 2019;10:424. https:\/\/doi.org\/10.3389\/fnagi.2018.00424. PMID: 30687076; PMCID: PMC6333733.","DOI":"10.3389\/fnagi.2018.00424"},{"issue":"5","key":"4375_CR82","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/jmri.24665","volume":"41","author":"X Bai","year":"2015","unstructured":"Bai X, Edden RA, Gao F, Wang G, Wu L, Zhao B, et al. Decreased \u03b3-aminobutyric acid levels in the parietal region of patients with alzheimer\u2019s disease. J Magn Reson Imaging. 2015;41(5):1326\u201331.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4375_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0269881120972331","volume":"35","author":"CH Chang","year":"2021","unstructured":"Chang CH, Lin CH, Liu CY, Huang CS, Chen SJ, Lin WC, et al. Plasma d-glutamate levels for detecting mild cognitive impairment and alzheimer\u2019s disease: machine learning approaches. J Psychopharmacol. 2021;35(3):265\u201372.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"4375_CR84","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1038\/s41598-017-13951-7","volume":"7","author":"CH Lin","year":"2017","unstructured":"Lin CH, Yang HT, Chiu CC, Lane HY. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. Sci Rep. 2017;7(1):14849.","journal-title":"Sci Rep"},{"issue":"2","key":"4375_CR85","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-2010-1398","volume":"20","author":"B Aisa","year":"2010","unstructured":"Aisa B, Gil-Bea FJ, Solas M, Garc\u00eda-Alloza M, Chen CP, Lai MK, et al. Altered NCAM expression associated with the cholinergic system in alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(2):659\u201368.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"4375_CR86","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","volume":"27","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Tsang SW, Gil-Bea FJ, Francis PT, Lai MK, Marcos B, et al. Involvement of the GABAergic system in depressive symptoms of alzheimer\u2019s disease. Neurobiol Aging. 2006;27(8):1110\u20137.","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"4375_CR87","first-page":"269","volume":"105","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"1998","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Molina JA, G\u00f3mez P, Vargas C, de Bustos F, Benito-Le\u00f3n J, et al. Neurotransmitter amino acids in cerebrospinal fluid of patients with alzheimer\u2019s disease. J Neural Transm (Vienna). 1998;105(2\u20133):269\u201377.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"4375_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02252617","volume":"6","author":"M Martinez","year":"1993","unstructured":"Martinez M, Frank A, Diez-Tejedor E, Hernanz A. Amino acid concentrations in cerebrospinal fluid and serum in alzheimer\u2019s disease and vascular dementia. J Neural Transm Park Dis Dement Sect.\u00a01993;6(1):1\u20139.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"4","key":"4375_CR89","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3233\/JAD-142925","volume":"45","author":"J Olazar\u00e1n","year":"2015","unstructured":"Olazar\u00e1n J, Gil-de-G\u00f3mez L, Rodr\u00edguez-Mart\u00edn A, Valent\u00ed-Soler M, Frades-Payo B, Mar\u00edn-Mu\u00f1oz J, et al. A blood-based, 7-metabolite signature for the early diagnosis of alzheimer\u2019s disease. J Alzheimers Dis. 2015;45(4):1157\u201373.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"4375_CR90","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archneur.1982.00510230035010","volume":"39","author":"SR Bareggi","year":"1982","unstructured":"Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S. Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in alzheimer\u2019s disease. Age- or disease-related modifications? Arch Neurol. 1982;39(11):709\u201312.","journal-title":"Arch Neurol"},{"issue":"1","key":"4375_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000466688","volume":"7","author":"G Corso","year":"2017","unstructured":"Corso G, Cristofano A, Sapere N, la Marca G, Angiolillo A, Vitale M, et al. Serum amino acid profiles in normal subjects and in patients with or at risk of alzheimer dementia. Dement Geriatr Cogn Dis Extra. 2017;7(1):143\u201359.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"4","key":"4375_CR92","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.57.4.671","volume":"57","author":"C Ferrarese","year":"2001","unstructured":"Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001;57(4):671\u20135.","journal-title":"Neurology"},{"issue":"9","key":"4375_CR93","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","volume":"34","author":"MC Gueli","year":"2013","unstructured":"Gueli MC, Taibi G. Alzheimer\u2019s disease: amino acid levels and brain metabolic status. Neurol Sci. 2013;34(9):1575\u20139.","journal-title":"Neurol Sci"},{"issue":"3","key":"4375_CR94","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00726-021-02943-7","volume":"53","author":"T Nuzzo","year":"2021","unstructured":"Nuzzo T, Mancini A, Miroballo M, Casamassa A, Di Maio A, Donati G, et al. High performance liquid chromatography determination of L-glutamate, L-glutamine and Glycine content in brain, cerebrospinal fluid and blood serum of patients affected by alzheimer\u2019s disease. Amino Acids. 2021;53(3):435\u201349.","journal-title":"Amino Acids"},{"issue":"4","key":"4375_CR95","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0197-4580(84)90009-5","volume":"5","author":"H Arai","year":"1984","unstructured":"Arai H, Kobayashi K, Ichimiya Y, Kosaka K, Iizuka R. A preliminary study of free amino acids in the postmortem Temporal cortex from Alzheimer-type dementia patients. Neurobiol Aging. 1984;5(4):319\u201321.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"4375_CR96","first-page":"340","volume":"26","author":"M Oishi","year":"1996","unstructured":"Oishi M, Mochizuki Y, Yoshihashi H, Takasu T, Nakano E. Laboratory examinations correlated with severity of dementia. Ann Clin Lab Sci. 1996;26(4):340\u20135.","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"4375_CR97","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ana.410190307","volume":"19","author":"H Sasaki","year":"1986","unstructured":"Sasaki H, Muramoto O, Kanazawa I, Arai H, Kosaka K, Iizuka R. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of alzheimer type. Ann Neurol. 1986;19(3):263\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"4375_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3940(92)90321-W","volume":"141","author":"H Tohgi","year":"1992","unstructured":"Tohgi H, Abe T, Takahashi S, Kimura M. A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with alzheimer type dementia compared with vascular dementia of the Binswanger type. Neurosci Lett. 1992;141(1):5\u20138.","journal-title":"Neurosci Lett"},{"key":"4375_CR99","doi-asserted-by":"publisher","first-page":"1219718","DOI":"10.3389\/fnagi.2023.1219718","volume":"15","author":"G Berezhnoy","year":"2023","unstructured":"Berezhnoy G, Laske C, Trautwein C. Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and alzheimer\u2019s disease patients. Front Aging Neurosci. 2023;15:1219718.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"4375_CR100","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/archneur.1984.04210080010005","volume":"41","author":"R Zimmer","year":"1984","unstructured":"Zimmer R, Teelken AW, Trieling WB, Weber W, Weihmayr T, Lauter H. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of alzheimer\u2019s type. Arch Neurol. 1984;41(6):602\u20134.","journal-title":"Arch Neurol"},{"issue":"4","key":"4375_CR101","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02252924","volume":"2","author":"H Basun","year":"1990","unstructured":"Basun H, Forssell LG, Almkvist O, Cowburn RF, Ekl\u00f6f R, Winblad B, et al. Amino acid concentrations in cerebrospinal fluid and plasma in alzheimer\u2019s disease and healthy control subjects. J Neural Transm Park Dis Dement Sect.\u00a01990;2(4):295\u2013304.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"S121","key":"4375_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0404.1989.tb04875.x","volume":"79","author":"LG Forssell","year":"1989","unstructured":"Forssell LG, Ekl\u00f6f R, Winblad B, Forssell L. Early stages of late onset alzheimer\u2019s disease. Acta Neurol Scand. 1989;79(S121):27\u201342.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"4375_CR103","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000022031","volume":"44","author":"N Redjems-Bennani","year":"1998","unstructured":"Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gu\u00e9ant JL. Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from alzheimer patients. Gerontology. 1998;44(5):300\u20134.","journal-title":"Gerontology"},{"issue":"4","key":"4375_CR104","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.410210403","volume":"21","author":"TL Perry","year":"1987","unstructured":"Perry TL, Yong VW, Bergeron C, Hansen S, Jones K. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with alzheimer\u2019s disease. Ann Neurol. 1987;21(4):331\u20136.","journal-title":"Ann Neurol"},{"issue":"9","key":"4375_CR105","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","volume":"35","author":"P Liu","year":"2014","unstructured":"Liu P, Fleete MS, Jing Y, Collie ND, Curtis MA, Waldvogel HJ, et al. Altered arginine metabolism in alzheimer\u2019s disease brains. Neurobiol Aging. 2014;35(9):1992\u20132003.","journal-title":"Neurobiol Aging"},{"key":"4375_CR106","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fpsyt.2018.00561","volume":"9","author":"C Madeira","year":"2018","unstructured":"Madeira C, Vargas-Lopes C, Brand\u00e3o CO, Reis T, Laks J, Panizzutti R, et al. Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable alzheimer\u2019s disease and depression. Front Psychiatry. 2018;9:561.","journal-title":"Front Psychiatry"},{"issue":"2","key":"4375_CR107","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/jnr.20241","volume":"78","author":"LR White","year":"2004","unstructured":"White LR, G\u00e5rseth M, Aasly J, Sonnewald U. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor. J Neurosci Res. 2004;78(2):297\u2013301.","journal-title":"J Neurosci Res"},{"issue":"4","key":"4375_CR108","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1212\/WNL.42.4.733","volume":"42","author":"RL Albin","year":"1992","unstructured":"Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology. 1992;42(4):733\u20138.","journal-title":"Neurology"},{"issue":"1","key":"4375_CR109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-2007-11113","volume":"11","author":"CP Jacob","year":"2007","unstructured":"Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, et al. Alterations in expression of glutamatergic transporters and receptors in sporadic alzheimer\u2019s disease. J Alzheimers Dis. 2007;11(1):97\u2013116.","journal-title":"J Alzheimers Dis"},{"key":"4375_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2017.10.011","volume":"1678","author":"S Huang","year":"2018","unstructured":"Huang S, Tong H, Lei M, Zhou M, Guo W, Li G, et al. Astrocytic glutamatergic transporters are involved in A\u03b2-induced synaptic dysfunction. Brain Res. 2018;1678:129\u201337.","journal-title":"Brain Res"},{"issue":"4","key":"4375_CR111","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1041\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"4375_CR112","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","volume":"78","author":"CM Lauderback","year":"2001","unstructured":"Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the alzheimer\u2019s disease brain: the role of Abeta1-42. J Neurochem. 2001;78(2):413\u20136.","journal-title":"J Neurochem"},{"key":"4375_CR113","doi-asserted-by":"publisher","unstructured":"Takado Y, Sato N, Kanbe Y, Tomiyasu M, Xin L, Near J, et al. Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC\/MS. Nutrients. 2019;11(7):1649. https:\/\/doi.org\/10.3390\/nu11071649.\u00a0PMID: 31330962; PMCID: PMC6682979.","DOI":"10.3390\/nu11071649"},{"key":"4375_CR114","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/B978-0-12-407824-6.00070-7","volume-title":"Diet and nutrition in dementia and cognitive decline","author":"J Chen","year":"2015","unstructured":"Chen J, Herrup K. Chapter 70 - Glutamine as a potential neuroprotectant in alzheimer\u2019s disease. In: Martin CR, Preedy VR, editors. Diet and nutrition in dementia and cognitive decline. San Diego: Academic; 2015. pp. 761\u201371."},{"issue":"5","key":"4375_CR115","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.26464","volume":"92","author":"L Sun","year":"2022","unstructured":"Sun L, Guo D, Jia Y, Shi M, Yang P, Wang Y, et al. Association between human blood metabolome and the risk of alzheimer\u2019s disease. Ann Neurol. 2022;92(5):756\u201367.","journal-title":"Ann Neurol"},{"key":"4375_CR116","doi-asserted-by":"publisher","unstructured":"Baek JH, Kang JS, Song M, Lee DK, Kim HJ. Glutamine supplementation preserves glutamatergic neuronal activity in the infralimbic cortex, which delays the onset of mild cognitive impairment in 3\u00d7Tg-AD female mice. Nutrients. 2023;15(12):2794. https:\/\/doi.org\/10.3390\/nu15122794. PMID: 37375700; PMCID: PMC10303714.","DOI":"10.3390\/nu15122794"},{"issue":"15","key":"4375_CR117","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1002\/cne.25207","volume":"529","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang L, Zhou D, Li H, Xu Y. ErbB4 mediates amyloid \u03b2-induced neurotoxicity through jnk\/tau pathway activation: implications for alzheimer\u2019s disease. J Comp Neurol. 2021;529(15):3497\u2013512.","journal-title":"J Comp Neurol"},{"issue":"1","key":"4375_CR118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","volume":"98","author":"M Martinez-Losa","year":"2018","unstructured":"Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, et al. Nav1.1-Overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of alzheimer\u2019s disease. Neuron. 2018;98(1):75\u2013e895.","journal-title":"Neuron"},{"issue":"3","key":"4375_CR119","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.stem.2019.12.015","volume":"26","author":"J Zheng","year":"2020","unstructured":"Zheng J, Li HL, Tian N, Liu F, Wang L, Yin Y, et al. Interneuron accumulation of phosphorylated Tau impairs adult hippocampal neurogenesis by suppressing GABAergic transmission. Cell Stem Cell. 2020;26(3):331\u2013e456.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"4375_CR120","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/alz.12088","volume":"16","author":"D Bi","year":"2020","unstructured":"Bi D, Wen L, Wu Z, Shen Y. GABAergic dysfunction in excitatory and inhibitory (E\/I) imbalance drives the pathogenesis of alzheimer\u2019s disease. Alzheimers Dement. 2020;16(9):1312\u201329.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"4375_CR121","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.biopsych.2003.10.013","volume":"55","author":"H Tomita","year":"2004","unstructured":"Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry. 2004;55(4):346\u201352.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"4375_CR122","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.1979.tb05223.x","volume":"33","author":"EG Spokes","year":"1979","unstructured":"Spokes EG, Garrett NJ, Iversen LL. Differential effects of agonal status on measurements of GABA and glutamate decarboxylase in human post-mortem brain tissue from control and huntington\u2019s chorea subjects. J Neurochem. 1979;33(3):773\u20138.","journal-title":"J Neurochem"},{"issue":"3","key":"4375_CR123","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1471-4159.2003.01747.x","volume":"85","author":"MR Hynd","year":"2003","unstructured":"Hynd MR, Lewohl JM, Scott HL, Dodd PR. Biochemical and molecular studies using human autopsy brain tissue. J Neurochem. 2003;85(3):543\u201362.","journal-title":"J Neurochem"},{"issue":"2","key":"4375_CR124","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.1981.tb01608.x","volume":"36","author":"TL Perry","year":"1981","unstructured":"Perry TL, Hansen S, Gandham SS. Postmortem changes of amino compounds in human and rat brain. J Neurochem. 1981;36(2):406\u201310.","journal-title":"J Neurochem"},{"issue":"7","key":"4375_CR125","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci. 2010;13(7):812\u20138.","journal-title":"Nat Neurosci"},{"key":"4375_CR126","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Frausto M, Bilash OM, Masurkar AV, Basu J. Local and long-range GABAergic circuits in hippocampal area CA1 and their link to alzheimer\u2019s disease. Front Neural Circuits. 2023;17:1223891. https:\/\/doi.org\/10.3389\/fncir.2023.1223891. PMID: 37841892; PMCID: PMC10570439.","DOI":"10.3389\/fncir.2023.1223891"},{"issue":"10","key":"4375_CR127","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1523\/JNEUROSCI.16-10-03311.1996","volume":"16","author":"A Solodkin","year":"1996","unstructured":"Solodkin A, Veldhuizen SD, Van Hoesen GW. Contingent vulnerability of entorhinal Parvalbumin-Containing neurons in alzheimer\u2019s disease. J Neurosci. 1996;16(10):3311.","journal-title":"J Neurosci"},{"issue":"4","key":"4375_CR128","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"4375_CR129","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/hipo.10188","volume":"14","author":"D Ramonet","year":"2004","unstructured":"Ramonet D, Rodr\u00edguez MJ, Fredriksson K, Bernal F, Mahy N. In vivo neuroprotective adaptation of the glutamate\/glutamine cycle to neuronal death. Hippocampus. 2004;14(5):586\u201394.","journal-title":"Hippocampus"},{"issue":"6","key":"4375_CR130","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1042\/BST20130237","volume":"41","author":"CF Rose","year":"2013","unstructured":"Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans. 2013;41(6):1518\u201324.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"4375_CR131","doi-asserted-by":"publisher","first-page":"e33177","DOI":"10.1371\/journal.pone.0033177","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Herrup K. Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H2O2-induced stress. PLoS ONE. 2012;7(3):e33177.","journal-title":"PLoS ONE"},{"issue":"4\u20135","key":"4375_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0197-0186(99)00150-3","volume":"36","author":"SR Robinson","year":"2000","unstructured":"Robinson SR. Neuronal expression of glutamine synthetase in alzheimer\u2019s disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int. 2000;36(4\u20135):471\u201382.","journal-title":"Neurochem Int"},{"issue":"23","key":"4375_CR133","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","volume":"88","author":"CD Smith","year":"1991","unstructured":"Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in alzheimer disease. Proc Natl Acad Sci U S A. 1991;88(23):10540\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4375_CR134","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s11064-005-8654-x","volume":"30","author":"G Burbaeva","year":"2005","unstructured":"Burbaeva G, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS. Glutamate metabolizing enzymes in prefrontal cortex of alzheimer\u2019s disease patients. Neurochem Res. 2005;30(11):1443\u201351.","journal-title":"Neurochem Res"},{"issue":"10","key":"4375_CR135","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/archneur.56.10.1241","volume":"56","author":"H Tumani","year":"1999","unstructured":"Tumani H, Shen G, Peter JB, Br\u00fcck W. Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for alzheimer disease? Arch Neurol. 1999;56(10):1241\u20136.","journal-title":"Arch Neurol"},{"issue":"24","key":"4375_CR136","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1073\/pnas.89.24.11949","volume":"89","author":"D Gunnersen","year":"1992","unstructured":"Gunnersen D, Haley B. Detection of glutamine synthetase in the cerebrospinal fluid of alzheimer diseased patients: a potential diagnostic biochemical marker. Proc Natl Acad Sci U S A. 1992;89(24):11949\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4375_CR137","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neurobiolaging.2014.12.010","volume":"36","author":"NM Timmer","year":"2015","unstructured":"Timmer NM, Herbert MK, Claassen JA, Kuiperij HB, Verbeek MM. Total glutamine synthetase levels in cerebrospinal fluid of alzheimer\u2019s disease patients are unchanged. Neurobiol Aging. 2015;36(3):1271\u20133.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"4375_CR138","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/pr5000895","volume":"13","author":"G Wang","year":"2014","unstructured":"Wang G, Zhou Y, Huang FJ, Tang HD, Xu XH, Liu JJ, et al. Plasma metabolite profiles of alzheimer\u2019s disease and mild cognitive impairment. J Proteome Res. 2014;13(5):2649\u201358.","journal-title":"J Proteome Res"},{"issue":"1","key":"4375_CR139","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66\u201377.","journal-title":"Lancet Neurol"},{"issue":"12","key":"4375_CR140","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, et al. The alzheimer\u2019s association appropriate use recommendations for blood biomarkers in alzheimer\u2019s disease. Alzheimers Dement. 2022;18(12):2669\u201386.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"4375_CR141","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H. Biomarkers for alzheimer\u2019s disease: current status and prospects for the future. J Intern Med. 2018;284(6):643\u201363.","journal-title":"J Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04375-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04375-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04375-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:05:44Z","timestamp":1757415944000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04375-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4375"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04375-2","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved with the ethical code IR.SBMU.REC.1403.652.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}